Cellectar Biosciences Inc.

NASDAQ: CLRBHealthcare / Biotechnology / USA
2.13-0.0400-1.84%Vol 39 9031Y Perf -23.21%
Aug 20th, 2019 16:00
BID2.13 ASK2.15
Open2.19 Previous Close2.17
Pre-Market- After-Trading2.10
 - -%  -0.03 -1.41%
Target Price
5.13 
Analyst Rating
Strong Buy 1.00
Potencial %
140.85 
Finscreener Ranking
 —    -
Insiders Trans % 3/6/12M
-/100/20 
Value Ranking
 —    -
Insiders Value % 3/6/12M
-/100/10 
Growth Ranking
 —    -
Insiders Shares Cnt. % 3/6/12M
-/100/9 
Income Ranking
 —    -
Market Cap (mil)20 
Earnings Rating
Strong Buy
Price Range Ratio 52wk %
29.74 
Earnings Date
9th Aug 2019

Today's Price Range

2.122.19

52wk Range

1.224.28

Summary:

Sell

Technical Indicators: Neutral
Moving Averages: Strong Sell
Performance
1 Week
0.95%
1 Month
1.43%
3 Months
8.12%
6 Months
4.93%
1 Year
-23.21%
3 Years
-91.45%
5 Years
-99.29%
10 Years
-100.00%

Name / TickerPriceChg.Chg.%
CLRB2.13-0.0400-1.84
AAPL210.610.26000.12
GOOG1 182.69-15.7600-1.32
MSFT137.26-1.1500-0.83
XOM69.03-0.4200-0.60
WFC44.68-0.5700-1.26
JNJ130.60-1.6500-1.25
FB183.81-2.3600-1.27
GE8.38-0.2900-3.34
JPM107.31-1.3800-1.27
Earnings HistoryEstimateReportedSurprise %
Q02 2019-0.60-0.4623.33
Q01 2019-0.50-0.76-52.00
Q03 2018--1.65-
Q02 2018--1.69-
Q01 2018--2.10-
Q04 2017--340.00-
Q03 2017-2.50-2.60-4.00
Q02 2017--2.30-
Earnings Per EndEstimateRevision %Trend
9/2019 QR-0.580.00-
12/2019 QR-0.430.00-
12/2019 FY-1.9518.75Positive
12/2020 FY-0.9028.57Positive
Next Report Date-
Estimated EPS Next Report-0.60
Estimates Count1
EPS Growth Next 5 Years %-
Volume Overview
Volume39 903
Shares Outstanding (in ths.)9 396
Trades Count148
Dollar Volume112 704
Avg. Volume274 998
Avg. Weekly Volume45 482
Avg. Monthly Volume73 346
Avg. Quarterly Volume148 203
Analyst RatingsCurrent1 M ago3 M ago
Strong Buy
3 (100.00 %)
2 (100.00 %)
2 (100.00 %)
Moderate Buy
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Hold
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Moderate Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Strong Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
RatingStrong Buy
1.00
Strong Buy
1.00
Strong Buy
1.00

Cellectar Biosciences Inc.

Cellectar Biosciences Inc is a clinical stage biopharmaceutical company. It focusses on development of targeted phospholipid drug conjugates for the treatment and imaging of cancer. The company's pipeline consists of pre-clinical and clinical product candidates including radiotherapeutic and chemotherapeutic phospholipid drug conjugates. Its portfolio of products in development includes CLR 131, CTX Product Portfolio consisting of CTX CLR 1800-P, CTX CLR 1602-PTX and CTX CLR 1700, CLR 125, CLR 124, and CLR 1502.

CEO: James V. Caruso

Teplephone: +1 608 441-8120

Address: 100 Campus Drive, Florham Park 07932, NJ, USA

Bearish or Bullish?
WeekMonthThree MonthsSix Months

Bearish Bullish

100%0%

Bearish Bullish

50%50%

Bearish Bullish

50%50%

Bearish Bullish

58%42%

News